Plus   Neg

Toyota Motor Corp. Announces Executive, Organizational Changes - Quick Facts

Toyota Motor Corp. (TYT.L,TM) announced plans to change its executive lineup and revise its organizational structure in January 2018 to further strengthen cooperation among companies of the Group. The changes aim to renew the roles of executive vice presidents, and establish the new post of "fellow". In addition to supporting the president, executive vice presidents, as executive officers, are to be positioned as chairpersons and presidents of TMC's in-house companies and as organizational-group chief officers to directly oversee their areas of responsibility. The executive lineup is to now include people both inside and originally from outside the company with a high level of expertise.

The company announced changes to operating officers and fellow effective January 1, 2018. New executive vice presidents include: Koji Kobayashi Vice chairman, member of the board, Denso Corp.; Shigeki Tomoyama; and Moritaka Yoshida. The areas of responsibility of Koji Kobayashi will now include Chief financial officer and Chief risk officer. The areas of responsibility of Shigeki Tomoyama will include chief officer, TPS Group.

Gill Pratt CEO, Toyota Research Institute, Inc., has been named new fellow. His responsibility will now include CEO, Toyota Research Institute, Inc. Advanced R&D and Engineering Company (fellow).

As part of the plans, the corporate management-related divisions and the Business Planning & Operation business unit are to be restructured. The Japan Sales Business Group is to be restructured and based on regions rather than sales channels. The TPS Group is to be newly created.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
An administrative law judge has ruled that Minnesota regulators should approve Enbridge Inc.'s proposal to replace its aging Line 3 crude oil pipeline only if the company follows the existing route and not its preferred route. Enbridge has applied to replace its Line 3 pipeline from Alberta with new pipe along its existing route. In Minnesota, the planned route deviates from the existing route. CLICK HERE to see America's 10 Best-Selling Drugs Despite high drug costs, most of the top-selling drugs saw sales gains in 2017 compared to the prior year. A large number of the best-selling drugs are primarily for the treatment and management of cancer, diabetes, inflammatory disorders, and HIV... Most Americans have access to health care, though costs and services vary from state to state. However, higher costs do not necessarily translate into better results. The U.S. continues to be outperformed by other wealthy nations on several measures like life expectancy, disease burden and health...
Follow RTT